SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-03-000010
Filing Date
2003-03-21
Accepted
2003-03-21 17:19:03
Documents
11
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 2002 FORM 10K ligand200210k.htm 10-K 1027900
3 EX 10.250 ex10-250.txt EX-10 117546
4 EX 10.251 ex10-251.txt EX-10 27837
5 EX 10.252 ex10-252.txt EX-10 17003
6 EX 10.253 ex10-253.txt EX-10 4441
7 EX 10.254 ex10-254.txt EX-10 8505
8 EX 10.255 ex10-255.txt EX-10 45557
9 EX 21.1 ex21-1.txt EX-21 1027
10 EX 23.1 ex23-1.txt EX-23 824
11 EX 99.1 CEO CERT ex99-1.txt EX-99 1418
12 EX 99.2 CFO CERT ex99-2.txt EX-99 1418
  Complete submission text file 0000886163-03-000010.txt   1256060
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 03612845
SIC: 2834 Pharmaceutical Preparations